Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202511750700989Phase 0Not yet recruiting
Phase 0 trial of pregabalin in anaesthesia (2 arms), sponsored by Ahmed Ayman Abdelrady. Primary endpoint: Hemodynamic changes in response to laryngoscopy and intubation. Planned start Nov 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202511750700989.